LEN vs MPLT · rev $14.56B vs $1.24B cap
LEN (LEN) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported LEN revenue for 2026-05-31 was $14.56B. Net income was $534.2M. LEN currently screens at market cap $0.
MPLT does not have a complete income-statement cache yet.
LEN currently screens at market cap $0. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the LEN and MPLT stock pages for the full models.
Not investment advice.